Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

At this time of year, we like to recognize the people and companies that have helped drive innovation and success – but we need your help.

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.